Announcements Trials

Browse Landscape

Phase

Phase 1 4 Phase 1/2 3 Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Myeloid 2 CNS 1

Conditions

Ependymoma 1 Brain Neoplasms 1

Interventions

Temozolomide 17 Magnetic Resonance Spectroscopy 16 Radiotherapy 10 Bevacizumab 7 fluciclovine F-18 6 Specimen Handling 6 Topotecan 5 Cyclophosphamide 5 Biopsy 5 fluorodopa F 18 4 abemaciclib 4 Vincristine 4 Surgical Procedures, Operative 4 Ketoconazole 4 Irinotecan 4 Fluorodeoxyglucose F18 4 Ferrosoferric Oxide 4 ribociclib 3 gallium Ga 68 dotatate 3 etoposide phosphate 3 Radiation 3 Pemetrexed 3 Nivolumab 3 Methotrexate 3 Mesna 3 Everolimus 3 Etoposide 3 Carboplatin 3 posaconazole 2 poly ICLC 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Azacitidine × CNS × Clear all

NCT02940483 2018-11-30

5-AZA

The University of Texas Health Science Center, Houston

Phase EARLY_PHASE1 Completed

Brain Neoplasms, Ependymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡